Vital Therapies
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch VTL and buy or sell other stocks, ETFs, and their options commission-free!About VTL
Immunic, Inc. is a clinical-stage biopharmaceutical company, which develops a pipeline of selective oral immunology therapies aimed at treating chronic inflammatory and autoimmune diseases. It focuses on ulcerative colitis, Crohn’s disease, relapsing-remitting multiple sclerosis, and psoriasis.
CEODaniel Vitt, PhD
CEODaniel Vitt, PhD
Employees—
Employees—
HeadquartersNew York, New York
HeadquartersNew York, New York
Founded2003
Founded2003
Employees—
Employees—
VTL Key Statistics
Market cap68.15M
Market cap68.15M
Price-Earnings ratio-0.65
Price-Earnings ratio-0.65
Dividend yield—
Dividend yield—
Average volume1.52M
Average volume1.52M
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$1.39
52 Week high$1.39
52 Week low$0.561
52 Week low$0.561
Stock Snapshot
As of today, Vital Therapies(VTL) shares are valued at $7.76. The company's market cap stands at 68.15M, with a P/E ratio of -0.65.
On 2025-12-19, Vital Therapies(VTL) stock opened at —, reached a high of —, and a low of —.
The Vital Therapies(VTL)'s current trading volume is 0, compared to an average daily volume of 1.52M.
In the last year, Vital Therapies(VTL) shares hit a 52-week high of $1.39 and a 52-week low of $0.56.
In the last year, Vital Therapies(VTL) shares hit a 52-week high of $1.39 and a 52-week low of $0.56.